Wordt geladen...
A Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonist in Kidney Transplant Recipients With Type 2 Diabetes
Diabetic kidney disease (DKD), a devastating complication of diabetes, is one of the leading causes of end stage kidney disease (ESKD). Kidney transplantation provides superior outcomes for ESKD patients with type 2 diabetes, giving opportunities to be free from dialysis, but needs lifetime immunosu...
Bewaard in:
| Gepubliceerd in: | J Endocr Soc |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8090345/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.826 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|